The Hong Kong insurer’s steady expansion across key non-life segments and capital support from its parent underpin improved performance and balance sheet strength.
The agency also said it will set K-ICS ratio regulations within the year and review surrender value reserve rules to reinforce capital quality and solvency oversight.